期刊文献+

精神分裂症患者的胆红素特点及转归 被引量:1

Characteristics and outcomes of bilirubin in drug naive patients with schizophrenia
原文传递
导出
摘要 目的 探索精神分裂症患者的胆红素特点及用药后的转归情况.方法 选择新入院精神分裂症患者81例作为研究组,77名健康体检者作为对照组,收集对照组及研究组用药前后的总胆红素(T-BIL)、直接胆红素(D-BIL)、间接胆红素(I-BIL)、丙氨酸转氨酶(ALT)资料进行分析比较.结果 研究组用药前T-BIL、D-BIL、I-BIL、ALT水平与对照组比较,差异无统计学意义(P>0.05),I-BIL异常率低于对照,差异有统计学意义(χ^2=4.286,P<0.05).用药后T-BIL、D-BIL、I-BIL下降,ALT升高,差异有统计学意义(P<0.05),且胆红素水平与肝功能的相关性消失.结论 精神分裂症患者存在氧化防御系统缺陷,用药后出现胆酶分离现象,提示抗精神病药物可能在其转归上起到重要作用. Objective To explore the characteristics ot bilirubin in drug naive patients with schizo- phrenia and its outcomes after antipsychotics treatment. Methods With 81 schizophrenia patients un treated at least three months before admitted to hospital as the case group, 77 healthy physical examination volunteers matched sex and age as control group, data of serum levels of total bilirubin (TB), conju gated bilirubin (CB), unconjugated hilirubin (UCB) and alanine aminotransferase (ALT) was collected and analyzed by chi square test and paired t test. Results The difference between levels of T--BIL, D-- BIL, I--BIL, ALT in case group and that in control group, was not statistically significant (P〈 0.05). The abnormal rate of I--BIL was lower than that of the control, the difference was statistically signifi- cant (χ^2= 4. 286, P 〈0.05). After antipsychotic treatment, T-- BIL, D-- BIL, I-- BIL decreased, and ALT increased, the difference was statistically significant (P 〈0.05), and the correlation disappeared. Conclusions The results support that patients with schizophrenia have defects in oxidative defense system. The phenomenon of bilirubin separation ALT after treatment suggests that antipsychotic drugs may play an important role in its outcomes.
出处 《神经疾病与精神卫生》 2014年第2期170-173,共4页 Journal of Neuroscience and Mental Health
关键词 精神分裂症 胆红素 氧化损伤 胆酶分离 Schizophrenia Bilirubin Oxidative damage Bilirubin separation ALT
  • 相关文献

参考文献16

  • 1McDonagh AF. Controversies in bilirubin biochemistry and their clinical relevance[J]. Semin Fetal Neonatal Med,2010, 15(3) :141-147.
  • 2Rigato I,Ostrow JD,Tiribelli C. Bilirubin and the risk of com- mon non- hepatic diseases [J]. Trends Mol Med, 2005, 11 (6) :277-283.
  • 3Radhakrishnan R, Kanigere M, Menon J, et al. Association between unconjugated bilirubin and schizophrenia[J]. Psychi- atry Res,2011,189(3) :480-482.
  • 4Miyaoka T. Schizophrenia and idiopathic unconjugated byper-bilirubinemia (Gilbert's syndrome) [J]. Seishin Shinkeigaku Zasshi,2007,109 (4) :306-312.
  • 5Wake R,Miyaoka T, Tsuchie K, et al. Abnormalities in MRI signal intensity in schizophrenia associated with idiopathic un- conjugated hyperbilirubinemia[J]. Aust N Z J Psychiatry, 2009,43(11) :1 057-1 069.
  • 6Yasukawa R, Miyaoka T, Yasuda H, et al. Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophrenia[J]. Psychiatry Res, 2007,153 ( 2 ) : 203-207.
  • 7Brites D, Fernandes A, Falco AS, et al. Biological risks for neurological abnormalities associated with hyperbilirubinemia [J]. J Perinatol,2009,29 Suppt 1:S8-S13.
  • 8Bach DR,Kindler J, Strik WK. Elevated bilirubin in acute and transient psychotic disorder[J]. Pharmaeopsychiatry, 2010,43 (1):12-16.
  • 9Miyaoka T, Yasukawa R,Yasuda H,et al. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders[J]. Eur Neuropsychophar- macol, 2005,15 (3) : 249- 252.
  • 10Reddy R, Keshavan M,Yao JK. Reduced plasma antioxidants in first-episode patients with schizophrenia[J]. Schizophr Res,2003,62(3) :205-212.

二级参考文献36

共引文献9

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部